NCT03845166 · Interventional trial
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Overall registry status Active not recruiting
Phase 1
Conditions Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant, Renal Cell Carcinoma
Delaware Valley sites
- Exelixis Clinical Site #58 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory